R619-M64-303: CMV51p> SARS-CoV-2 S(1-1208)-2P-T4f-3C-His8-Strep2x2 D614G Citations (2)

Originally described in: Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.
Esposito D, Mehalko J, Drew M, Snead K, Wall V, Taylor T, Frank P, Denson JP, Hong M, Gulten G, Sadtler K, Messing S, Gillette W Protein Expr Purif. 2020 Jun 4;174:105686. doi: 10.1016/j.pep.2020.105686. PubMed Journal

---

Articles Citing R619-M64-303: CMV51p> SARS-CoV-2 S(1-1208)-2P-T4f-3C-His8-Strep2x2 D614G

Articles
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Choe PG, Hong J, Park J, Chang E, Kang CK, Kim NJ, Lee CH, Park WB, Oh MD. J Infect Dis. 2022 Sep 28;226(7):1224-1230. doi: 10.1093/infdis/jiac099. PubMed
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naive individuals. Kang CK, Kim MG, Park SW, Kim YW, Lee CM, Choe PG, Park WB, Kim NJ, Kim M, Lee S, Kim IS, Lee CH, Shin HM, Kim HR, Oh MD. J Med Virol. 2023 Feb;95(2):e28558. doi: 10.1002/jmv.28558. PubMed

If you have published an article using this material, please email us at to have your article added to this page.